<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H8A248A96D1A04C40A28719F6BF6E1A9A" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 7505 IH: To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-04-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7505</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220414">April 14, 2022</action-date><action-desc><sponsor name-id="B001260">Mr. Buchanan</sponsor> (for himself and <cosponsor name-id="K000376">Mr. Kelly of Pennsylvania</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.</official-title></form><legis-body id="H8096928DD67747A7A49F3E5CC43EA847" style="OLC"><section id="HF60EA4EEDB0F463EB2C8B4DF55B6ACD3" section-type="section-one"><enum>1.</enum><header>New medical research expenditure component of credit for increasing research activities</header><subsection id="HA180FF1CA6044BF09930B7381E676A16"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline"><external-xref legal-doc="usc" parsable-cite="usc/26/41">Section 41(a)</external-xref> of the Internal Revenue Code of 1986 is amended by striking <quote>and</quote> at the end of paragraph (2), by striking the period at the end of paragraph (3) and inserting <quote>, and</quote>, and by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="HCC96E21FCB804BCFA3716C9BE7970A1B" display-inline="no-display-inline"><paragraph id="HA6399A2FA1A541A7946A97941405FD2F"><enum>(4)</enum><text display-inline="yes-display-inline">14 percent of specified medical research expenditures.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H8B59A8B075D54AC8B573B226D07DE958"><enum>(b)</enum><header>Specified medical research expenditures</header><text>Section 41(f) of such Code is amended by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="H9882FBEC1D914F6C9DBF1A4D3F513F25" display-inline="no-display-inline"><paragraph id="HE48547A46F074BCD97B45713800494E1"><enum>(7)</enum><header>Specified medical research expenditures</header><subparagraph id="H82D5216364B14D2488A6B7C1D1F44DC1"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">The term <quote>specified medical research expenditures</quote> means amounts paid or incurred for qualified research with respect to any qualified countermeasure.</text></subparagraph><subparagraph id="H94A6D18048624EB2A6D4B345963E23EB"><enum>(B)</enum><header>Qualified countermeasure</header><text display-inline="yes-display-inline">The term <quote>qualified countermeasure</quote> has the meaning given to such term in section 319F–1(a)(2) of the Public Health Service Act (42 U.S.C. 247d–6a(a)(2)).</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HAE6FC573616B490BA6FCC605DD7FC4F1"><enum>(c)</enum><header>Denial of double benefit</header><paragraph id="H2B846DC0B542455A929C0598D4C088C0"><enum>(1)</enum><header>Taxable years beginning before January <enum-in-header>1, 2022</enum-in-header></header><text display-inline="yes-display-inline">In the case of specified medical research expenditures (as defined in section 41(f)(7) of such Code (as added by this section)) paid or incurred in taxable years beginning before January 1, 2022—</text><subparagraph id="HE928AE5280F7417587177787D11E345C"><enum>(A)</enum><text>such expenditures shall be treated in the same manner as qualified research expenses and basic research expenses under section 280C(c)(1) of such Code (as in effect on the day before the enactment of the Tax Cuts and Jobs Act), and</text></subparagraph><subparagraph id="HA68B13D0CF664D40991DB28AC312D793"><enum>(B)</enum><text>the amount determined under section 280C(c)(2)(A) (as in effect on such day) for the taxable year shall be increased by the amount of credit determined for the taxable year under section 41(a)(4) (as added by this section).</text></subparagraph></paragraph><paragraph id="H8C1851FA25194E60906F175C456D8237"><enum>(2)</enum><header>Taxable years beginning after December <enum-in-header>31, 2021</enum-in-header></header><text display-inline="yes-display-inline">Section 280C(c)(1) of such Code is amended by striking <quote>section 41(a)(1)</quote> and inserting <quote>paragraphs (1) and (4) of section 41(a)</quote>. </text></paragraph></subsection><subsection id="H4B14EDCD3340436CB1120AD597A6563F"><enum>(d)</enum><header>Conforming amendment</header><text>Section 41(f)(1) of such Code is amended by striking <quote>and amounts paid or incurred to energy research consortiums</quote> each place it appears and inserting <quote>, amounts paid or incurred to energy research consortiums, and specified medical research expenditures</quote>.</text></subsection><subsection id="H17137C17E96343488B2B52CEF6B26F7F" commented="no"><enum>(e)</enum><header>Effective date</header><text>The amendments made by this section shall apply to amounts paid or incurred after the date of the enactment of this Act, in taxable years ending after such date.</text></subsection></section></legis-body></bill> 

